Search research articles
Contact Us
Filters
Showing results (701-710 of 740) with videos related to
Page
of 74
Sort By:
JAMA
|
February 28, 2018
Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial
Keith S Kaye, Tanaya Bhowmick, Symeon Metallidis, et al.
Scientific Reports
|
July 29, 2025
A network analysis of carbapenem-resistant Klebsiella pneumoniae among healthcare facilities
Courtney L Luterbach, Dana K Pasquale, Heather I Henderson, et al.
American Journal of Infection Control
|
January 31, 2012
The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities
Dror Marchaim, Teena Chopra, Christopher Bogan, et al.
Microbiology Spectrum
|
May 23, 2023
Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii
Hadas Kon, Amichay Hameir, Amir Nutman, et al.
Antimicrobial Agents and Chemotherapy
|
February 23, 2012
Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia
Kayoko Hayakawa, Dror Marchaim, Emily T Martin, et al.
Infectious Diseases and Therapy
|
October 2, 2018
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial
Richard G Wunderink, Evangelos J Giamarellos-Bourboulis, Galia Rahav, et al.
Infection Control and Hospital Epidemiology
|
April 9, 2014
Introduction to "A Compendium of Strategies To Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 updates"
Deborah S Yokoe, Deverick J Anderson, Sean M Berenholtz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 6, 2003
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer
M J Piccart, K Bertelsen, G Stuart, et al.
Infection Control and Hospital Epidemiology
|
September 30, 2014
Introduction to "A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates"
Deborah S Yokoe, Deverick J Anderson, Sean M Berenholtz, et al.
Journal of the National Cancer Institute
|
May 4, 2000
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results
M J Piccart, K Bertelsen, K James, et al.
Page
of 74
Search research articles
Search
Showing results (701-710 of 740) with videos related to
Sort By:
Page
of 74
JAMA
|
February 28, 2018
Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial
Keith S Kaye, Tanaya Bhowmick, Symeon Metallidis, et al.
Scientific Reports
|
July 29, 2025
A network analysis of carbapenem-resistant Klebsiella pneumoniae among healthcare facilities
Courtney L Luterbach, Dana K Pasquale, Heather I Henderson, et al.
American Journal of Infection Control
|
January 31, 2012
The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities
Dror Marchaim, Teena Chopra, Christopher Bogan, et al.
Microbiology Spectrum
|
May 23, 2023
Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii
Hadas Kon, Amichay Hameir, Amir Nutman, et al.
Antimicrobial Agents and Chemotherapy
|
February 23, 2012
Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia
Kayoko Hayakawa, Dror Marchaim, Emily T Martin, et al.
Infectious Diseases and Therapy
|
October 2, 2018
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial
Richard G Wunderink, Evangelos J Giamarellos-Bourboulis, Galia Rahav, et al.
Infection Control and Hospital Epidemiology
|
April 9, 2014
Introduction to "A Compendium of Strategies To Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 updates"
Deborah S Yokoe, Deverick J Anderson, Sean M Berenholtz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 6, 2003
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer
M J Piccart, K Bertelsen, G Stuart, et al.
Infection Control and Hospital Epidemiology
|
September 30, 2014
Introduction to "A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates"
Deborah S Yokoe, Deverick J Anderson, Sean M Berenholtz, et al.
Journal of the National Cancer Institute
|
May 4, 2000
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results
M J Piccart, K Bertelsen, K James, et al.
Page
of 74